Abstract:Since the discovery of rapamycin, considerable progress has been made in unraveling the details of the mammalian target of rapamycin (mTOR) signaling network, including the upstream mechanisms that modulate mTOR signaling functions, and the roles of mTOR in the regulation of mRNA translation and other cell growth-related responses. mTOR is found in two different complexes within the cell, mTORC1 and mTORC2, but only mTORC1 is sensitive to inhibition by rapamycin. mTORC1 is a master controller of protein synthesis, integrating signals from growth factors within the context of the energy and nutritional conditions of the cell. Activated mTORC1 regulates protein synthesis by directly phosphorylating 4E-binding protein 1 (4E-BP1) and p70S6K (S6K), translation initiation factors that are important to cap-dependent mRNA translation, which increases the level of many proteins that are needed for cell cycle progression, proliferation, angiogenesis, and survival pathways. In normal physiology, the roles of mTOR in both glucose and lipid catabolism underscore the importance of the mTOR pathway in the production of metabolic energy in quantities sufficient to fuel cell growth and mitotic cell division. Several oncogenes and tumor-suppressor genes that activate mTORC1, often through the phosphatidylinositol 3-kinase (PI3K)/AKT pathway, are frequently dysregulated in cancer. Novel analogs of rapamycin (temsirolimus, everolimus, and deforolimus), which have improved pharmaceutical properties, were designed for oncology indications. Clinical trials of these analogs have already validated the importance of mTOR inhibition as a novel treatment strategy for several malignancies. Inhibition of mTOR now represents an attractive anti-tumor target, either alone or in combination with strategies to target other pathways that may overcome resistance. The far-reaching downstream consequences of mTOR inhibition make defining the critical molecular effector mechanisms that mediate the anti-tumor response and associated biomarkers that predict responsiveness to mTOR inhibitors a challenge and priority for the field.

Regulation of mTORC1 by Upstream Stimuli

Amino Acid Regulation of TOR Complex 1.

Mtorc1, the Master Regulator of Autophagy

Nutrient regulation of mTORC1 at a glance

Post-translational Regulation of the Mtorc1 Pathway: A Switch That Regulates Metabolism-Related Gene Expression

Regulatory Function of Phosphorylation and Ubiquitination on The TORC1 Signaling Pathway

Regulation of mTORC1 by the Rag GTPases

THE mTOR SIGNALING PATHWAY AND THE REGULATION OF CELL GROWTH

Regulation Of Mtorc1 By The Rab And Arf Gtpases

Substrate-specific regulation of mTORC1 activity by G protein-coupled receptors

Conserved regulators of Rag GTPases orchestrate amino acid-dependent TORC1 signaling

mTOR Signaling in Growth Control and Disease

The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease

mTOR Signaling, Function, Novel Inhibitors, and Therapeutic Targets

Mechanistic Target of Rapamycin Complex 1: From a Nutrient Sensor to a Key Regulator of Metabolism and Health

Current Models of Mammalian Target of Rapamycin Complex 1 (mtorc1) Activation by Growth Factors and Amino Acids

RagC phosphorylation autoregulates mTOR complex 1

The mammalian target of rapamycin pathway and its role in molecular nutrition regulation.

Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.

Sensors for the Mtorc1 Pathway Regulated by Amino Acids

Advances in the Mechanisms of Amino Acid Signaling in mTORC1 Pathway